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Purpose
This study was conducted to explore the process and operation of a cancer multidisciplinary
team (MDT) after the reimbursement decision in Korea, and to identify ways to overcome
the major barriers to effective and sustainable MDTs. 
Materials and Methods
Approximately 1,000 cancer specialists, including medical oncologists, surgical oncologists,
radiation oncologists, pathologists, and radiologists in general hospitals in Korea were invited
to complete the survey. The questionnaire covered the following topics: organizational struc-
ture of MDTs, candidates for consulting, the clinical decision-making initiative, and respon-
sibility for dealing with legal disputes. 
Results
We collected a total of 179 responses (18%) from physicians at institutions where an MDT
approach was active. A surgical oncologist (91%), internist (90%), radiologist (89%), radiation
oncologist (86%), pathologist (71%), and trainees (20%) regularly participated in MDT 
operations. Approximately 55% of respondents stated that MDTs met regularly. In cases of
a split opinion, the physician in charge (69%) or chairperson (17%) made the final decision,
and most (86%) stated they followed the final decision. About 15% and 32% of respondents
were “very satisfied” and “satisfied,” respectively, with the current MDT’s operations. Among
38 institutional representatives, 34% responded that the MDT operation became more 
active and 18% stated an MDT was newly implemented after the reimbursement decision.  
Conclusion
The reimbursement decision invigorated MDT operations in almost half of eligible hospitals.
Dissatisfaction regarding current MDTs was over 50%, and the high discordance rates 
regarding risk sharing suggest that it is necessary to revise the current system of MDTs. 
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Introduction
To manage patients with advanced cancer in the most 
effective way, experts from different disciplines need to be
engaged [1]. This need has resulted in introduction of the
multidisciplinary team (MDT) approach, in which key pro-
fessionals discuss a particular patient and contribute inde-
pendently to clinical decisions [2]. Communication, coor-
dination, and decision making between healthcare profes-
sionals and patients have improved with the implementation
of the MDT approach [3]. 
Because of these advantages, current clinical guidelines
recommend discussing the diagnostic and/or therapeutic
plan with an MDT for localized or locally advanced non-
small cell lung cancer [4], synchronous metastatic/first 
recurrent metachronous metastatic colon cancer [5], locore-
gional stomach cancer [6], and most types of head and neck
cancer [7]. Although the concepts of the MDT approach are
considered good clinical practice in oncology, MDT organi-
zation and implementation take a substantial amount of time
and additional efforts by the team’s relevant healthcare pro-
fessionals. In addition, there are practical barriers to active
and sustainable implementation of an MDT [3].  
To improve patient-centered cancer care by invigorating
the MDT approach and to enhance the benefits coverage in
recompense for abrogation of the physician surcharge, the
Korean Health Authority decided to reimburse the costs of
the “Multidisciplinary Care Service” on August 1, 2014. The
Korean model of the MDT is provided for patients in supe-
rior general hospitals or the Korea cancer center hospitals
who have a clinically suspicious or pathologically confirmed
malignancy. The MDT includes four or more-expert services
and is offered in the outpatient clinic as a face-to-face service
between patient and physicians. The hospital can charge
113,210 won (102 US dollars) for the 4-expert service or
141,510 Korean won (128 US dollars) for the 5- or more-
expert service up to three times per primary tumor.
This study was conducted to explore the process and 
operation of cancer MDTs after the reimbursement decision
was made in Korea, and to identify ways to overcome the
major barriers to effective and sustainable MDTs. 
Materials and Methods
1. Development of the survey
Survey Monkey (https://ko.surveymonkey.com) was used
to create a web-based online survey. The survey consisted of
25 questions about the structure, extent, and functioning of
MDTs in Korea. A follow-up questionnaire consisted of four
items concerning changes in practice after the reimbursement
decision went into effect.
2. Participants
To complete the survey, we invited approximately 1,000
members of the Korean Association for Clinical Oncology,
Korean Society of Surgical Oncology, Korean Society for 
Radiation Oncology, Korean Society of Pathologists, and 
Korean Society of Radiology including medical oncologists,
surgical oncologists, radiation oncologists, pathologists, and
radiologists, as well as trainees, nurses, and clinical research
coordinators. The follow-up survey was only sent to repre-
sentative medical oncologists in each hospital as part of the
Survey of Medical Oncology Status in Korea (SOMOS-K) [8].
From October 2014 to January 2015, e-mail invitations 
including a link to the survey were sent to participants after
approval from the relevant society. Repeated invitations after
the initial distribution were sent to non-responders 8 weeks
and again 12 weeks later. Responses were automatically col-
lected by the online server.  
3. Statistical analysis
“Respondent” refers to an attending physician who is the
institutional representative that completed the questionnaire.
Fisher exact test with a significance level of < 0.05 was used
to compare differences in binary variables. All statistical
analyses were performed using the Stata ver. 13.0 software
(Stata Corp LP, College Station, TX).
Results
1. Responses
Included in the study were 179 responses from physicians
at institutions where an MDT approach was active (Table 1).
Of these 179 respondents, 70 (39%) were internists (58 med-
ical oncologists, 12 pulmonologists), 23 (13%) surgeons, 22
(12%) radiation oncologists, 41 (23%) radiologists, and 23
(13%) pathologists. A total of 38 institutional representatives
responded to a follow-up questionnaire.
2. Structure and functioning of MDTs
The MDT meetings were regularly attended by surgical
oncologist (91%), an internist including a medical oncologist
and pulmonologists (90%), radiologist (89%), radiation 
oncologist (86%), pathologist (71%), and trainees including
residents or fellows (20%) (Table 2). A total of 86% of the
MDTs had a designated (56%) or rotated (30%) chairperson.
Overall, 55% of the respondents stated that their MDTs met
regularly, 30% every week, 19% more than once a week, 4%
every 2 weeks, and 1% every month. 
A total of 60% of MDTs discussed cancer patients in all
stages, and the majority (98%) of MDTs meetings were held
to determine the therapeutic plan after the pathological 
diagnosis. 
3. Clinical decision making
In case of a split opinion, the physician in charge (69%) or
chairperson (17%) made the final decision and there was a
majority vote (15%) (Table 3). About 90% of respondents 
indicated that it was not mandatory for the treating physi-
cians to implement the final recommendation of the MDTs;
however, most (86%) indicated that they did follow the rec-
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ommendation. Regarding the hypothetical question of a law-
suit being brought by a patient who underwent treatment 
according to the decision of the MDT, 37% of respondents
stated that the treating physicians are responsible, while 38%
replied that all members of the MDT should share the 
responsibilities. In terms of the aforementioned risk-sharing
issues, experts from different disciplines had significantly
different opinions (p=0.039 between groups). Specifically, 
internists, surgeons, and radiation oncologists were more
likely to share their responsibility, while radiologists and
pathologists were less likely to accept responsibility for the
decision. 
4. Satisfaction  
About 15% and 32% of respondents were “very satisfied”
and “satisfied,” respectively, with how the current MDTs
functioned. Regarding the degree of satisfaction among 
experts from different disciplines, there was no significant
difference between experts (p=0.196). In particular, internists
and surgeons were more satisfied with MDTs than other doc-
tors were (p=0.027) (Fig. 1).
5. Changes after the reimbursement decision  
Among 38 institutional representatives, 34% (13/38) 
responded that MDT operations became more active and
18% (7/38) stated that an MDT was newly implemented after
the reimbursement decision.   
6. Barriers to improvements
More than half of respondents (56%) replied that the cur-
rent costs of reimbursement should be raised (the current
Table 1. Characteristics of the 179 respondents with an
MDT at their center
Characteristic No. (%)
Age group (yr)
30-40 49 (27)
40-50 78 (44)
> 50 52 (29)
Clinical career (yr)
< 5 24 (13)
5-10 49 (27)
10-20 60 (34)
> 20 46 (26)
Department
Internal Medicine 70 (39)
Medical Oncology 58 (32)
Pulmonology 12 (7)
General Surgery 23 (13)
Radiation Oncology 22 (12)
Radiology 41 (23)
Pathology 23 (13)
Specialty (multiple)
Stomach 59 (33)
Colon 60 (34)
Lung 78 (44)
Breast 51 (28)
Hepato-biliary 56 (31)
Genitourinary 40 (22)
Head and neck 49 (27)
Rare malignancy 36 (20)
179 (100)
MDT, multidisciplinary team.
Table 2. Structure of the MDT for cancer care in Korea
Structure Percentagea)
Participants
Internal Medicine 90
Radiology 89
General Surgery 91
Radiation Oncology 86
Pathology 71
Trainees (residents or fellows) 20
Chairperson
No 14
Yes -
Designated 56
Rotating 30
Schedule
Irregular meeting (in case) 45
Regular meeting 55
More than one meeting a week 19
Every week 30
Every 2 weeks 4
Every month 1
Stage in discussion
All stages 60
Localized stage 39
Recurrent or metastatic stage 27
Reasons for an MDT
To diagnose cancer 2
To decide therapeutic plan after diagnosis 98
To decide palliative care plan after recurrence 0
a)We calculated the proportion of answers based on 70 mul-
tidisciplinary teams (MDTs) of 179 respondents. 
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cost is 113,210 Korean won/102 US dollar for 4-expert serv-
ices, and 141,510 won/128 US dollar for 5- or more-expert
services). About 42% insisted that multidisciplinary care
service should be expanded to include inpatient MDTs.
Moreover, 30% demanded that the option of face-to-face
meetings should be eliminated and the number of experts
who participate in MDTs should be regulated. Finally, 12%
of respondents noted that prerequisites regarding the insti-
tutions allowed to have an MDT should be relaxed from 
superior general hospital to general hospitals. 
Discussion
We found that the reimbursement decision made by gov-
ernment health authorities invigorated MDT operations in
almost half of eligible hospitals, suggesting that the reim-
bursement decision could affect our practice considerably.
Moreover, dissatisfaction of over 50% regarding current
MDTs and high discordance rates regarding risk sharing
were observed. Given the absence of specific guidance for
MDTs, the implementation and organizational structure
were variable across institutions. 
The reimbursement to the “Multidisciplinary Care Serv-
ice” has changed the practice patterns of healthcare profes-
sionals in Korea considerably. Approximately one third of
institutional representatives stated that the MDT operation
became more active and 18% responded that an MDT was
newly implemented. Despite these changes, a few important
issues concerning regulations remain. Specifically, 56% of 
respondents stated that the cost of MDTs is not sufficient.
Table 3. Responses to various questions in the survey, 
especially pertaining to clinical decision making 
Question Percentagea)
Who makes the final decision/
recommendation in case there 
is more than one opinion?
Physician in charge 69
Chairperson 17
Majority vote 15
Is it mandatory for the treating doctor 
to implement the decision/
recommendation of the MDT?
Yes 8
No, but follow the decision/ 86
recommendation
No, decide regardless of 6
the decision/recommendation
In case of a lawsuit brought on by 
a patient who underwent treatment 
according to the decision of the MDT, 
who do you think is/are
legally responsible?
All members of the MDT 38
Treating doctor 37
Hospital 18
Chairperson 3
Others 3
a)We calculated the proportion of answers based on 70 mul-
tidisciplinary teams (MDTs) of 179 respondents. 
Internists
Radiation oncologists
Surgical oncologists 
Radiologists
Pathologists
20 40 60 80 100 (%)0 10 30 50 70 90
Not satisfied Indeterminate Satisfied Very satisfied
36 193411
15
272745
102550
5 8
6
3355
6 3356
Fig. 1. Satisfaction with how the current multidisciplinary team functioned. p=0.196 between groups. p=0.027 between 
internists/surgical oncologists versus radiation oncologists/radiologists/pathologists.
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Currently, the MDT operation costs 102 US dollars for 
4-expert service, which is approximately 25 US dollars per
individual expert’s consultation. In cases in which participa-
tion in MDT requires considerable time and extra effort (in
our survey, more than half of respondents noted that), the
current cost of reimbursement should be raised. Addition-
ally, 42% of respondents stated that a restriction to outpatient
consultation in MDT is not rational. According to the rule of
outpatient consultation, the hospital cannot charge a service
fee for inpatient MDT consultation. Our respondents were
concerned that restriction to outpatient consultation will
eventually discourage the experts’ willingness to participate
in MDT. Additionally, the current regulations do not accept
the non-face-to-face form of MDT, including discussions in
conference and tumor boards. Finally, 12% of respondents
expressed concern that the prerequisites regarding eligible
institutions (reimbursement for only 43 superior general hos-
pitals or one Korean cancer center hospital) could limit the
chance to join MDTs by patients as well as healthcare pro-
fessionals. These barriers expressed by healthcare providers
might limit the expansion of MDTs and cause perfunctory
meetings to be held only to collect payments. Therefore, stan-
dard guidelines and the establishment of a flexible MDT
model are necessary.   
MDTs could improve clinical outcomes and patient satis-
faction by shortening the time to diagnosis and therapeutic
intervention, improving adherence to guidelines, and greater
inclusion in clinical trials [9-11]. However, evidence for sur-
vival benefit and efficiency are not strong [3,12,13]. There-
fore, future investigations regarding the effectiveness of
MDT operations in Korea are warranted. Additionally, par-
ticipation in a discussion between experts from different dis-
ciplines will help improve physicians’ practical knowledge
beyond theoretical information. Our survey showed that
only 20% of MDT meetings invited residents or fellows.
Therefore, we actively recommend that our trainees partici-
pate in MDTs. 
Some limitations must be noted. First, our study had a low
response rate. This was primarily because we did not send
our questionnaire to active members with current clinical 
activities, but rather to all members of corresponding aca-
demic societies, which include faculties, trainees, nurses, and
clinical research coordinators. To overcome this limitation,
we sent a follow-up questionnaire concerning changes in
practice after reimbursement decision only to representative
medical oncologists in each hospital. Second, the retrospec-
tive nature of our survey is subject to recall bias of all respon-
dents. Because there is a paucity of data regarding MDT
before the reimbursement decision, we directly asked our 
respondents about the actual changes in clinical practice 
between pre and post reimbursement, which might have
caused recall bias.   
The start of the “Multidisciplinary Care Service” is an 
important step in optimal cancer care in the Korean health
system. The unceasing efforts to establish the best model and
the proper rewards are necessary to expand MDTs across the
country. Moreover, investigation of the outcome after the 
reimbursement decision is warranted to revise regulations
and influence the regulatory body. 
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